Lesley Ann Calhoun

CIK 1730866 · See Remarks · last filed 2026-06-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$510.5K

Companies

3

Total Filings

33

Lifetime Open-Market Net

-$2.58M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TNGX Director 16,500 $30.94 $510.5K $36.0K 5 2026-06-08
ALGS See Remarks $5.28 $0 11 2026-03-11
Global Blood Therapeutics, Inc. (GBT) Delisted See Remarks 2,854 $68.49 $195.5K -$2.61M 17 2020-05-28

Recent Filings · Page 2 of 4

33 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-06-08 TNGX Grant (A) +5,000 $0 EDGAR
2023-03-17 ALGS Grant (A) $0 EDGAR
2022-07-11 ALGS Grant (A) $0 EDGAR
2022-06-28 TNGX Grant (A) $0 EDGAR
2022-02-08 ALGS Grant (A) $0 EDGAR
2020-12-03 ALGS Grant (A) $0 EDGAR
2020-05-28 Global Blood Therapeutics, Inc. (GBT) Delisted Mixed -$108.9K EDGAR
2020-05-20 Global Blood Therapeutics, Inc. (GBT) Delisted Mixed -$1.23M EDGAR
2020-05-13 Global Blood Therapeutics, Inc. (GBT) Delisted Sell (S) −3,373 -$263.9K EDGAR
2020-03-04 Global Blood Therapeutics, Inc. (GBT) Delisted Mixed +196 -$6.7K EDGAR
Showing 1120 of 33
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.